04.29.16
PAREXEL
3Q Revenues: $611.4 million (+6%)
3Q Earnings: $47.9 million (+27%)
YTD: Revenues: $1.8 billion (+21%)
YTD: Earnings: $112.2 million (1%)
Comments: Clinical Research Services (CRS) revenue was flat at $402.8 million, PAREXEL Consulting (PC) revenue was up 49% to $49.9 million, and PAREXEL Informatics (PI) revenue was $74.4 million, up 11%. Backlog as of March 31, 2016 was $5.7 billion, an increase of 9.1% year-over-year.
3Q Revenues: $611.4 million (+6%)
3Q Earnings: $47.9 million (+27%)
YTD: Revenues: $1.8 billion (+21%)
YTD: Earnings: $112.2 million (1%)
Comments: Clinical Research Services (CRS) revenue was flat at $402.8 million, PAREXEL Consulting (PC) revenue was up 49% to $49.9 million, and PAREXEL Informatics (PI) revenue was $74.4 million, up 11%. Backlog as of March 31, 2016 was $5.7 billion, an increase of 9.1% year-over-year.
